Abstract
BackgroundThe addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery improves recurrence-free and overall survival in patients with FIGO stage III ovarian cancer who are ineligible for primary cytoreductive...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have